Assembly Biosciences (ASMB) Metrics: History & Chart

Assembly Biosciences, Inc.(ASMB)

Biotechnology · South San Francisco, CA

$22.74+0.20 (+0.89%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Assembly Biosciences, Inc.

Assembly Biosciences, Inc. is a biotechnology firm in the clinical development phase, dedicated to identifying and advancing innovative therapeutic solutions for hepatitis B virus (HBV) infections within the United States. Its primary drug candidate, Vebicorvir, has successfully concluded Phase 2 clinical trials for individuals with chronic HBV. The company's development pipeline also features ABI-H3733, which has finished Phase 1a clinical studies, and ABI-4334, currently in pre-clinical assessment for HBV treatment. Assembly Biosciences has forged collaborative partnerships, including agreements with BeiGene, Ltd. and Arbutus Biopharma Corporation, as well as with Antios Therapeutics, Inc., to explore a triple-combination treatment strategy for chronic hepatitis B virus. Additionally, it maintains strategic licensing arrangements with Indiana University Research and Technology Corporation and Door Pharmaceuticals, LLC. Established in 2005, the company was formerly known as Ventrus Biosciences, Inc. before rebranding to Assembly Biosciences, Inc. in June 2014, and its headquarters are located in South San Francisco, California.

South San Francisco, CA

73 employees

www.assemblybio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Jason A. Okazaki

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-3.68%
30D Total Return	-37.87%
YTD Total Return	-33.14%
1Y Total Return	-2.49%
3Y Total Return	+139.85%
5Y Total Return	-43.08%
10Y Total Return	-76.30%
15Y Total Return	-95.74%
20Y Total Return	N/A

2026	-33.14%
2025	+115.53%
2024	+60.37%
2023	-36.92%
2022	-44.21%
2021	-61.49%
2020

CAGR TTM	-2.48%
CAGR 3Y	+33.85%
CAGR 5Y	-10.66%
CAGR 10Y	-13.41%
CAGR 15Y	-18.97%
CAGR 20Y	N/A

PE Ratio	41.35
PE Ratio Avg TTM	54.06
PE Ratio Avg 3Y	54.06
Current VS TTM Avg	-23.50%
Current VS 3Y Avg	-23.50%
Current VS 5Y Avg	-23.50%

All Metrics

ASMB Valuation Metrics

ASMB Stock Price Metrics

ASMB Dividend Metrics

ASMB Growth Rate Metrics

ASMB Discounted Cash Flow Metrics

ASMB Returns By Period

ASMB Yearly Returns

ASMB Average Annual Returns By Period (CAGR)

ASMB Revenue Metrics

ASMB PE Ratio Metrics

ASMB PS Ratio Metrics

ASMB PB Ratio Metrics

ASMB Price to Free Cash Flow Ratio Metrics

ASMB Debt to Equity Ratio Metrics

ASMB PEG Ratio Metrics

ASMB FCF Yield

ASMB Earnings Yield

ASMB EBITDA Yield

ASMB OCF Yield

ASMB EV/EBIT Ratio Metrics

ASMB EV/EBITDA Ratio Metrics

ASMB EV/Assets Ratio Metrics

ASMB EV/Sales Ratio Metrics

ASMB Current Ratio Metrics

ASMB Quick Ratio Metrics

ASMB ROIC Metrics

ASMB Return on Assets Metrics

ASMB Return on Equity Metrics

ASMB Net Profit Margin Metrics

ASMB Gross Profit Margin Metrics

ASMB Tax Rate Metrics

PS Ratio	5.73
PS Ratio Avg TTM	6.26
PS Ratio Avg 3Y	5.60
Current VS TTM Avg	-8.51%
Current VS 3Y Avg	+2.40%
Current VS 5Y Avg	-32.40%

PB Ratio	1.40
PB Ratio Avg TTM	1.71
PB Ratio Avg 3Y	2.26
Current VS TTM Avg	-18.06%
Current VS 3Y Avg	-38.14%
Current VS 5Y Avg	-8.91%

PFCF Ratio	2.97
PFCF Ratio Avg TTM	3.58
PFCF Ratio Avg 3Y	3.58
Current VS TTM Avg	-17.03%
Current VS 3Y Avg	-17.03%
Current VS 5Y Avg	-17.03%

Debt/Equity Ratio	0.01
Debt/Equity Ratio Avg TTM	0.04
Debt/Equity Ratio Avg 3Y	0.04
Current VS TTM Avg	-81.46%
Current VS 3Y Avg	-82.53%
Current VS 5Y Avg	-78.04%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	33.64%
FCF Yield Avg TTM	28.70%
FCF Yield Avg 3Y	28.70%
Current VS TTM Avg	+17.23%
Current VS 3Y Avg	+17.23%
Current VS 5Y Avg	+17.23%

Earnings Yield	2.42%
Earnings Yield Avg TTM	1.91%
Earnings Yield Avg 3Y	1.91%
Current VS TTM Avg	+27.00%
Current VS 3Y Avg	+27.00%
Current VS 5Y Avg	+27.00%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	1.21
Ev/Assets Ratio Avg TTM	1.42
Ev/Assets Ratio Avg 3Y	0.88
Current VS TTM Avg	-14.88%
Current VS 3Y Avg	+38.11%
Current VS 5Y Avg	+130.35%

Ev/Sales Ratio	5.33
Ev/Sales Ratio Avg TTM	5.68
Ev/Sales Ratio Avg 3Y	4.51
Current VS TTM Avg	-6.22%
Current VS 3Y Avg	+18.30%
Current VS 5Y Avg	-8.28%

Current Ratio	13.99
Current Ratio Avg TTM	6.39
Current Ratio Avg 3Y	4.01
Current VS TTM Avg	+119.07%
Current VS 3Y Avg	+248.61%
Current VS 5Y Avg	+108.30%

Quick Ratio	13.99
Quick Ratio Avg TTM	6.39
Quick Ratio Avg 3Y	4.01
Current VS TTM Avg	+119.07%
Current VS 3Y Avg	+248.61%
Current VS 5Y Avg	+108.30%

ROIC	(2.86%)
ROIC Avg 3Y	(70.21%)
ROIC Avg 5Y	(77.10%)
Current VS 3Y Avg	+95.92%
Current VS 5Y Avg	+96.29%
Current VS 10Y Avg	+94.58%

ROA	(0.01%)
ROA Avg TTM	(2.58%)
ROA Avg 3Y	(7.39%)
Current VS TTM Avg	+99.61%
Current VS 3Y Avg	+99.86%
Current VS 5Y Avg	+99.92%

ROE	(0.01%)
ROE Avg TTM	(48.51%)
ROE Avg 3Y	(109.80%)
Current VS TTM Avg	+99.98%
Current VS 3Y Avg	+99.99%
Current VS 5Y Avg	+99.99%

Net Profit Margin	(0.06%)
Net Profit Margin Avg TTM	(55.71%)
Net Profit Margin Avg 3Y	(84.13%)
Current VS TTM Avg	+99.89%
Current VS 3Y Avg	+99.93%
Current VS 5Y Avg	+99.91%

Gross Profit Margin	99.82%
Gross Pft Margin Avg TTM	35.64%
Gross Pft Margin Avg 3Y	17.45%
Current VS TTM Avg	+180.07%
Current VS 3Y Avg	+471.94%
Current VS 5Y Avg	+6556.18%

Tax Rate	0.00%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A